Emergent BioSolutions
EBS
#6766
Rank
โ‚ฌ0.54 B
Marketcap
10,22ย โ‚ฌ
Share price
-1.24%
Change (1 day)
18.25%
Change (1 year)

Emergent BioSolutions (EBS) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.21 Billion

According to Emergent BioSolutions 's latest financial reports the company has โ‚ฌ0.21 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Emergent BioSolutions - Cash on Hand chart (from 2004 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ95.61 M-5.37%
2023-12-31โ‚ฌ0.10 B-83.13%
2022-12-31โ‚ฌ0.59 B17.76%
2021-12-31โ‚ฌ0.50 B0.71%
2020-12-31โ‚ฌ0.50 B237.22%
2019-12-31โ‚ฌ0.14 B52.73%
2018-12-31โ‚ฌ98.07 M-34%
2017-12-31โ‚ฌ0.14 B-42.43%
2016-12-31โ‚ฌ0.25 B-8.45%
2015-12-31โ‚ฌ0.28 B22.26%
2014-12-31โ‚ฌ0.23 B77.6%
2013-12-31โ‚ฌ0.12 B21.25%
2012-12-31โ‚ฌ0.10 B-4.65%
2011-12-31โ‚ฌ0.11 B-12.65%
2010-12-31โ‚ฌ0.12 B79.01%
2009-12-31โ‚ฌ71.83 M9.79%
2008-12-31โ‚ฌ65.43 M-9.64%
2007-12-31โ‚ฌ72.41 M25.03%
2006-12-31โ‚ฌ57.91 M89.03%
2005-12-31โ‚ฌ30.63 M509.31%
2004-12-31โ‚ฌ5.02 M
2002-12-31โ‚ฌ4.67 M-29.41%
2001-12-31โ‚ฌ6.62 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Merck
MRK
โ‚ฌ15.64 B 7,319.14%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚ฌ0.14 B-29.96%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ3.81 B 1,710.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ0.50 B 137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ12.86 B 6,003.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.89 B 797.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
โ‚ฌ9.04 M-95.71%๐Ÿ‡บ๐Ÿ‡ธ USA